Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Anticoagulation patient self-monitoring in the United States: considerations for clinical practice adoption.
Creation of PDX-Bearing Humanized Mice to Study Immuno-oncology.
Management of Type 1 Diabetes in Children in the First 5 Years of Life.
Matching-Adjusted Indirect Treatment Comparison to Assess the Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 Versus Belantamab Mafodotin in DREAMM-2, Selinexor-Dexamethasone in STORM Part 2, and Melphalan Flufenamide-Dexamethasone in HORIZON for the Treatment of Patients With Triple-Class Exposed Relapsed or Refractory Multiple Myeloma.
See All 4 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Management of Type 1 Diabetes in Children in the First 5 Years of Life.
Rearson M, Sullivan-Bolyai S. Management of Type 1 Diabetes in Children in the First 5 Years of Life. Pediatr Endocrinol Rev. 2017 Jun; 14(Suppl 2):412-421.
View in:
PubMed
subject areas
Caregivers
Child, Preschool
Choice Behavior
Diabetes Mellitus, Type 1
Humans
Infant
Infant, Newborn
Insulin Infusion Systems
Parents
authors with profiles
Susan Lynn Sullivan-Bolyai DNSc, MN, RN, CNS, FAAN